Terminology Service for NFDI4Health
All terms in BAO
| Label | Id | Description |
|---|---|---|
| hypoactive sexual desire disorder | DOID_13868 | |
| opioid abuse | DOID_11206 | [A substance abuse that involves the recurring use of opioid drugs despite negative consequences.] |
| multiple cranial nerve palsy | DOID_13866 | |
| allergic conjunctivitis | DOID_11204 | [A chronic conjunctivitis that is an inflammation of the conjunctiva involing red, itchy, and watery eyes a resulting from an exposure to an allergen or an irritant.] |
| acute closed-angle glaucoma | DOID_13862 | |
| von Willebrand's disease | DOID_12531 | [A coagulation protein disease that is a hereditary abnormality which slows the blood clotting process. It arises from a qualitative or quantitative deficiency of von Willebrand factor (vWF), a multimeric protein that is required for platelet adhesion.] |
| titration method | BAO_0002413 | |
| Karl Fischer titration | BAO_0002414 | [Karl Fischer titration is a classic titration method in analytical chemistry that uses coulometric or volumetric titration to determine trace amounts of water in a sample. It was invented in 1935 by the German chemist Karl Fischer.] |
| systolic heart failure | DOID_9651 | |
| dot immunobinding assay | BAO_0002415 | [Dot immunobinding assay (Dot Iba) is a simple and highly reproducible immunodiagnostic method. Antibody or antigen is dotted directly onto nitrocellulose membrane (NCM) discs. The diagnostic material to be checked can be incubated on this disc. Presence of antigen antibody complex in NCM discs can be directly demonstrated with enzyme-conjugated antiglobulins and substrate. Development of a purple-pink colored, insoluble substrate product in the NCM will be considered a positive result in the assay. This assay allows the processing of multiple specimens at a time.] |
| ocular motility disease | DOID_1279 | |
| checkerboard titration | BAO_0002416 | [A checkerboard titration is a single experiment in which the concentration of the two components is varied in a way that will result in a pattern. This method is often used to optimize reagent concentrations and to measure susceptibility to microbes to various agents.] |
| chemiluminescence-linked immunosorbent assay | BAO_0002417 | |
| dilution method | BAO_0002418 | |
| enzyme-linked immunosorbent spot assay | BAO_0002419 | [The ELISPOT assay is based on, and was developed from a modified version of the ELISA immunoassay. ELISPOT assays were originally developed to enumerate B cells secreting antigen-specific antibodies, and have subsequently been adapted for various tasks, especially the identification and enumeration of cytokine-producing cells at the single cell level. Simply put, at appropriate conditions the ELISPOT assay allows visualization of the secretory product of individual activated or responding cells. Each spot that develops in the assay represents a single reactive cell. Thus, the ELISPOT assay provides both qualitative (type of immune protein) and quantitative (number of responding cells) information.] |
| two site enzyme immunoassay | BAO_0002411 | [In a conventional 2-site enzyme immunoassay, the antigen under assay which must have two or more epitopes, is insolubilised by reaction with an unlabelled antibody conjugated to a solid phase and reacted with an enzyme-labelled antibody directed to a different (preferably roomly-spaced) epitope of the analyte. The quantity of labelled antibody which becomes immobilised due to the complexing reaction is directly proportional to the amount of analyte present in the sample.] |
| SAR by NMR | BAO_0002412 | |
| fluorescent DNA hybridization probe method | BAO_0002470 | |
| fluorescent labeling method | BAO_0002469 | |
| GO_0045449 | GO_0045449 |